BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy
· Delayed Price · Currency is EUR 62.60
-1.68 (-2.61%)
At close: Dec 5, 2025
BridgeBio Pharma Revenue
BridgeBio Pharma had revenue of $120.70M USD in the quarter ending September 30, 2025, with 4,318.01% growth. This brings the company's revenue in the last twelve months to $353.78M, up 62.46% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.
Revenue (ttm)
$353.78M
Revenue Growth
+62.46%
P/S Ratio
40.46
Revenue / Employee
$484.63K
Employees
730
Market Cap
12.20B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UniCredit | 24.85B |
| Intesa Sanpaolo | 25.32B |
| Enel SpA | 77.78B |
| Ferrari | 7.08B |
| Assicurazioni Generali | 56.79B |
| Eni S.p.A. | 86.56B |
| Stellantis | 146.12B |
| Leonardo S.p.a. | 19.13B |